Psoriasis Significantly Increases Risk of Metabolic Syndrome, Especially among those with Severe Disease: Study
Researchers have found in a recent systematic review and meta-analysis that psoriasis is an independent risk factor for metabolic syndrome (MetS), with a pooled prevalence of 26.49% among psoriasis patients. The risk is notably higher in those with more severe disease, as indicated by elevated PASI scores, indicating the role of disease activity in mediating MetS risk.
A study was done to explore the association between psoriasis and metabolic syndrome (MetS) and analyze the impact of disease activity on the risk of MetS occurrence. This systematic review and meta-analysis used computer searches to search for relevant literature on psoriasis and MetS in databases including China National Knowledge Infrastructure (CNKI), PubMed, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL) and Embase. The search period was from the establishment of the database to February 8, 2025. Inclusion in case-control, cohort studies and cross-sectional, with language restrictions in Chinese and English during retrieval. After independent screening of literature, extraction of data, and evaluation of risk bias for inclusion in the study by two evaluators, meta-analysis and subgroup analysis were conducted using Stata17.0 software. Result: A total of 12 studies were analyzed, encompassing 9,641 patients with psoriasis and 2,554 patients suffering from MetS alongside psoriasis. The incidence of metabolic syndrome in psoriasis patients was analyzed and the combined effect size was 26.49% [95% CI (25.61, 27.39%)]. Results from the meta-analysis indicated that, in comparison to the control group, psoriasis patients demonstrated a heightened risk of developing MetS [OR = 1.27, 95% CI (1.21-1.33), p < 0.001]. Subgroup analysis revealed that patients with severe psoriasis (PASI≥10) had a significantly increased risk of developing metabolic syndrome [OR = 2.25 95% CI (1.27, 3.99), p < 0.001], indicating that greater disease activity is associated with an elevated likelihood of MetS occurrence. Psoriasis is positively correlated with MetS risk, and increased disease activity further increases the risk. It is necessary to strengthen screening for metabolic abnormalities and multidisciplinary management.
Reference:
Li Z, Gu Z, Xiang J, Zhang X. The incidence of metabolic syndrome in psoriasis patients and its correlation with disease activity: a systematic review and meta-analysis. Front Med (Lausanne). 2025 May 2;12:1593003. doi: 10.3389/fmed.2025.1593003. PMID: 40385577; PMCID: PMC12081259.
Keywords:
Psoriasis, Significantly, Increases, Risk, Metabolic, Syndrome, Especially, among, those, Severe, Disease, Study, Li Z, Gu Z, Xiang J, Zhang X, disease activity; incidence; meta; metabolic syndrome; psoriasis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.